These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 857860)

  • 1. Depression of the platelet count after inoculation of mice with L1210 or L5178Y cells.
    Hacker M; Roberts D; Jackson C
    Br J Haematol; 1977 Mar; 35(3):465-71. PubMed ID: 857860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of VM-26 on the haematological responses of mice to L1210 leukaemia.
    Hacker M; Roberts D; Jackson CW
    Br J Cancer; 1980 Nov; 42(5):697-702. PubMed ID: 7459207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Shortened platelet survival as a cause of thrombocytopenia in mice with L1210 leukemia.
    Jackson CW; Krance RA; Edwards CC; Whidden MA; Gauthier PA
    Cancer Res; 1980 Mar; 40(3):667-70. PubMed ID: 7471085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of mouse erythroid colony formation by L1210 leukemia cells.
    Austin T; Ma A; Datta MC; Ortega JA; Shore NA; Dukes PP
    Exp Hematol; 1979 Feb; 7(2):63-73. PubMed ID: 428478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Murine leukemia: depressed response to interferon induction correlated with a serum hyporeactive factor.
    Stringfellow DA
    Infect Immun; 1976 Feb; 13(2):392-8. PubMed ID: 177366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Collateral sensitivity of resistant lines of mouse leukemias L1210 and L5178Y.
    Schmid FA; Hutchison DJ
    Cancer Res; 1972 Apr; 32(4):808-12. PubMed ID: 5014791
    [No Abstract]   [Full Text] [Related]  

  • 7. Predictive values of the in vivo diffusion chamber for cyclophosphamide treatment of L1210 murine leukemia.
    Anderson KC; Humphrey RL; Sensenbrenner LL
    Cancer Res; 1983 May; 43(5):2030-3. PubMed ID: 6831434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered platelet kinetics in thrombocytopenic mice with L5178Y leukemia.
    Scarborough V; Jackson CW; Whidden MA
    J Lab Clin Med; 1980 Nov; 96(5):822-9. PubMed ID: 7419965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antitumor activity of a water-insoluble compound entrapped in liposomes on L1210 leukemia in mice.
    Brassinne C; Atassi G; Frühling J; Penasse W; Coune A; Hildebrand J; Ruysschaert JM; Laduron C
    J Natl Cancer Inst; 1983 Jun; 70(6):1081-6. PubMed ID: 6574278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enzyme activity in mice with transplantable leukemia.
    Sobiech KA; Madej JA; Fiszer-Maliszewska L; Mazurkiewicz M
    Arch Immunol Ther Exp (Warsz); 1986; 34(1):35-43. PubMed ID: 2877646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential cell permeability and the basis for selective activity of methotrexate during therapy of the L1210 leukemia.
    Sirotnak FM; Donsbach RC
    Cancer Res; 1973 Jun; 33(6):1290-4. PubMed ID: 4718678
    [No Abstract]   [Full Text] [Related]  

  • 12. Potent antitumour activity of (-)-(R)-2-aminomethylpyrrolidine (1,1-cyclobutanedicarboxylato)platinum(II) monohydrate (DWA2114R) against advanced L1210 leukaemia in mice.
    Akamatsu K; Endo K; Matsumoto T; Kamisango K; Morikawa K; Koizumi M; Koizumi K
    Br J Cancer; 1992 Nov; 66(5):827-32. PubMed ID: 1419625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful immunotherapy with micrococcus, BCG or related polysaccharides on L1210 leukaemia after BCNU chemotherapy.
    Verloes R; Atassi G; Dumont P; Kanarek L
    Br J Cancer; 1981 Feb; 43(2):201-9. PubMed ID: 7470382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potentiation of L1210 murine leukemia vaccine in vivo by levamisole.
    Kataoka T; Tsukagoshi S; Sakurai Y; Okabe M
    Gan; 1979 Aug; 70(4):515-9. PubMed ID: 510850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemotherapy of lymph node metastasis by thigh and footpad inoculation of mouse leukemia L-1210 cells.
    Tsukagoshi S; Inouye T; Sakurai Y
    Gan; 1973 Apr; 64(2):189-91. PubMed ID: 4353207
    [No Abstract]   [Full Text] [Related]  

  • 16. Serum and host liver activities of glycosidases and sialyltransferases in animals bearing transplantable tumors.
    Bosmann HB; Spataro AC; Myers MW
    Res Commun Chem Pathol Pharmacol; 1975 Nov; 12(3):499-512. PubMed ID: 172998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activity of a novel anthracenyl bishydrazone, 9,10-anthracenedicarboxyaldehyde Bis[(4,5-dihydro-1H-imidazol-2-yl)hydrazone] dihydrochloride, against experimental tumors in mice.
    Citarella RV; Wallace RE; Murdock KC; Angier RB; Durr FE; Forbes M
    Cancer Res; 1982 Feb; 42(2):440-4. PubMed ID: 7055799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antitumor activity of 5-formamido-1- D-ribofuranosylthioimidazole-4-carboxamide 2',3',5'-triformate in a variety of animal tumors.
    Hoshi A; Kanzawa F; Kuretani K
    Cancer Chemother Rep; 1971 Jun; 55(3):229-31. PubMed ID: 5115844
    [No Abstract]   [Full Text] [Related]  

  • 19. The failure of normal haemopoiesis in rats during the development of acute leukaemia.
    Hoelzer D; Harriss EB
    Acta Haematol; 1973; 49(1):36-47. PubMed ID: 4632450
    [No Abstract]   [Full Text] [Related]  

  • 20. Glycocalyx of tumor cells.
    Roth J; Stiller D; Block F
    Exp Pathol (Jena); 1972; 6(1):35-46. PubMed ID: 4259824
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.